Singapore Patent for FGF2 Granted

A Singapore patent Nr. 11201804402W has been granted in respect of an invention of thermostable Fibroblast Growth Factor 2 (FGF2) polypeptide. The engineered FGF2 has improved thermal stability compared to the wild-type and is of use in the cell biology research, regenerative medicine and related medical applications or cosmetics.

Sincere congratulations to all inventors from both Masaryk University and Enantis.